Similar Items: Next-Generation version of pseudomonas exotoxin a based immunotoxins with reduced immunogenicity for triple negative breast cancer (TNBC) treatment
- Development Of Recombinant Immunotherapeutics for Triple-Negative Breast Cancer (TNBC)
- Regulation of rhamnolipid biosynthesis in the Pseudomonas aeruginosa PAOI biofilm population
- Towards the development of a pseudomonas aeruginosa DSM1707 biofilm specific expression system for producing alkaline protease
- Multiplasmids in Pseudomonas syringae pv. morsprunorum race 1
- Transcriptional analysis and mutagenesis of the htp fimbrial gene cluster from Pseudomonas aeruginosa PAO1
- Characterization of genetic elements up-regulated in Pseudomonas aeruginosa PAO biofilms and transcriptional activity of the flagellar hook protein gene, flgE, during biofilm development
Author: Barth, Stefan
- Evaluation of tumour-associated antigens to optically label cutaneous basal cell carcinoma for surgical excision
- Establishment of enhanced protein purification strategies for recombinant immunotherapeutics
- Generation of Glioblastoma specific SNAP based antibody fusion proteins for future radiolabelling application
- Development and Characterization of recombinant immunotoxins for cervical carcinoma
- Development of potential immunodiagnostic & therapeutic techniques using SNAP-fusion proteins as tools for the validation of Triple-negative Breast Cancer
- Comparison of the therapeutic efficacy of SNAP-tag fusion protein and the synergistic actions of chemotherapy and photodynamic therapy in killing resistant melanoma